Get the tools used by (smart)2 investors.
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

EBITDA Forecast Consensus Standard Deviation for GSK plc DRC

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

GSK: GSK plc DRC

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the ...

38.59 USD
Price
– USD
Fair Value
–
Upside
31.71 - 45.92
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on GSK plc DRC's EBITDA Forecast Consensus Standard Deviation:

Dec 2026Dec 2028Dec 2030Dec 2032Dec 20340 K500 M1 B1.5 B2 B2.5 B
Performance Summary
  • GSK plc DRC's ebitda forecast consensus standard deviation for the next fiscal year is 912.4 million
  • GSK plc DRC's ebitda forecast consensus standard deviation is expected to average 1.35 billion over the next 5 fiscal years.
  • GSK plc DRC's is expected to deliver median ebitda forecast consensus standard deviation of 912.4 million over the next 5 fiscal years.

How does GSK plc DRC's EBITDA Forecast Consensus Standard Deviation benchmark against competitors?

Hide this widget

We've identified the following companies as similar to GSK plc DRC because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

GSK plc DRC EBITDA Forecast Consensus Standard Deviation Benchmarks
NameTickerEBITDA Forecast Consensus Standard Deviation
HealthcareSECTOR:HLTH.GB0 K
Kyorin Holdings IncTSE:45690 K
Sandoz Group AGLSE:0SAN46.079 M
Genomma Lab Internacional SAB De CVBMV:LABB102 M
Merck KGaALSE:0O14137.4 M
H Lundbeck LLSE:0ND5368.9 M
Sanofi LLSE:0O59772.5 M
Novartis AGLSE:0QLR783.3 M
GSK plc DRCNYSE:GSK912.4 M
Merck & Co IncLSE:0QAH1.088 B
Roche Holding AG ParticipationLSE:0QOK1.249 B
AstraZeneca PLCLSE:AZN1.258 B

Metric Usage: EBITDA Forecast Consensus Standard Deviation

Hide this widget
ebitda_proj_stdev
Slug
number
Datatype
text
Format
current
Default Period
FY, Q
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to EBITDA Forecast Consensus Standard Deviation in the forecast category include:

View Full List

Search for metric or datapoint

EBITDA Forecast Consensus Standard Deviation

Standard deviation in forecasted EBITDA.

Definition of EBITDA Forecast Consensus Standard Deviation

Hide this widget
Standard deviation in forecasted EBITDA.

Sector Benchmark Analysis

All rights reserved. Terms Of Use